Proniras Corporation
Latest round
- Series B
Last raised
- Dec 2023
Total raised
- $4.6M
Investors
- 4
About Proniras Corporation
Based in Washington, US, and founded by its Chief Scientific Officer, Christopher Toombs, and Accelerator Life Science Partners in 2017, Proniras Corporation, operates as a developer of drugs used for the treatment of neurological conditions. The company offers AMPA (a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid), a kainate receptor antagonist for the treatment of seizures and brain injury. Other neurological disorders treated by the company include status epilepticus, pediatric epilepsy, and others.
Who invested in Proniras Corporation
4 investors across 1 round
See all investors in Proniras Corporation
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Dec 15, 2023
Amount
$4.6M
Investors
Questions about Proniras Corporation
Who invested in Proniras Corporation?
Proniras Corporation has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Proniras Corporation raised?
Proniras Corporation has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Proniras Corporation last raise money?
Proniras Corporation's most recent round on record is a Series B, in Dec 2023.
What does Proniras Corporation do?
Based in Washington, US, and founded by its Chief Scientific Officer, Christopher Toombs, and Accelerator Life Science Partners in 2017, Proniras Corporation, operates as a developer of drugs used for the treatment of neurological conditions.
Where is Proniras Corporation headquartered?
Proniras Corporation is headquartered in Seattle, US.
Which VCs invest in companies like Proniras Corporation?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Proniras Corporation's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Proniras Corporation? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.